Skip to content

4Accepted Sep 9, 5:53 PM ET

Vaxcyte CTO Harpreet Dhaliwal Surrenders 7,651 Shares

PCVXVaxcyte, Inc.

Accepted (ET)

5:53 PM

Sep 9, 2026

Filed

Sep 9, 2026

Documents

1

Size

5.0 KB

Summary

Vaxcyte CTO Harpreet Dhaliwal Surrenders 7,651 Shares

Updated

What Happened
Harpreet S. Dhaliwal, Chief Technical Ops Officer at Vaxcyte, surrendered 7,651 shares on 2026-09-08 at $60.36 per share (total value ≈ $461,814). This was a share disposition to satisfy tax withholding obligations tied to vested restricted stock units (RSUs), not an open-market sale.

Key Details

  • Transaction date: 2026-09-08; Filing date: 2026-09-09 (filed timely).
  • Price reported: $60.36 per share; Total value of surrendered shares: ~$461,814.
  • Shares surrendered: 7,651 (reported as a disposition under code F — tax withholding).
  • Footnote: F1 — shares were surrendered to the issuer to cover applicable tax withholding upon RSU vesting.
  • Shares owned after transaction: not provided in the supplied filing details.

Context
This was a routine tax-withholding disposition (cashless share surrender) related to RSU vesting — common for insiders and not the same as a market sale that might signal trading sentiment. The F code and footnote confirm the shares were retained by the company to cover taxes rather than sold on the open market.

AI-written summary · check the filing